Eurotech HiVe HPC System Now Generally Available With ARM

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Eurotech HiVe HPC System Now Generally Available With ARM CPUs

SANTA CLARA, Calif., Nov. 16, 2015 (GLOBE NEWSWIRE) -- Eurotech, a leading provider of supercomputing and embedded technologies, has announced that their HiVe HPC system is now generally available, not only with x86 CPUs, but also with ARM-64 based processors provided by Applied Micro Circuits Corporation (NASDAQ:AMCC).

The HiVe supercomputer leverages a new original high performance computing (HPC) system architecture combining extreme density and best-in-class energy efficiency. The new architecture is based on an innovative highly modular and scalable way of packaging electronics and water cooling, leaving no space unutilized and boasting record-breaking computational density. The HiVe is currently the densest HPC system in the market with a peak performance of more than 1 PFlop/s in one square meter (1.5 PFlop/s per square meter when equipped with NVIDIA Tesla K80).

For the ARM HiVe system development, Eurotech partnered with AppliedMicro, a California-based data center semiconductor company, utilizing the X-Gene processor, the world's first ARMv8-A Server on a Chip® solution. Eurotech has paired the X-Gene processor with NVIDIA® Tesla® and AMD FirePro™ GPU accelerators and Intel® Xeon™ coprocessors to efficiently deliver high performance for demanding HPC workloads.

The use of X-Gene processors adds to the already sound HiVe energy efficiency figures, taking them to extreme levels. An HiVe HPC system can perform at top efficiency in terms of sustained flops/watt and it exploits the latest generation of the Eurotech's patented direct hot liquid cooling, which allows "free cooling" even in the warmest climates on earth and features the best PUE in the industry. This means HiVe brings consistent energy savings at datacentre level.

The collaboration between AppliedMicro and Eurotech has also scored another goal. At the moment, HiVe is the only direct liquid cooled system that combines in a compact server 4 GPGPUs with a 64-bit ARM CPU.

"Eurotech has a track record of introducing revolutionary technologies to the HPC market, starting with the first direct hot liquid cooling products worldwide in 2009," – says Fabio Gallo, Eurotech Aurora GM – "The ARM-64 version of our HiVe accelerated supercomputer, which uses AppliedMicro's X-Gene processors, is no exception. It is the densest and most powerful ARM-64 based supercomputer in the industry."

The X-Gene processor utilizes a custom ARMv8-A microarchitecture developed to achieve a balance of maximum performance and power-efficiency. The X-Gene solution is a true Server on a Chip architecture providing 8 high performance processor cores coupled with the bandwidth of 4 high speed DDR memory channels and on-chip integration including 10 Gigabit Ethernet ports, a management processor, storage interfaces, and PCI-Express® Gen 3 I/O expansion.

"We are very excited to see Eurotech coupling their innovative HiVe architecture with AppliedMicro's X-Gene technology," said Kumar Sankaran, Associate Vice President of Software and Platforms at AppliedMicro. "The X-Gene architecture is optimized for high density compute platforms and is an ideal vehicle to enable Eurotech platforms to deliver leading-edge performance and cost-effectiveness."

The HiVe architecture allows for different types of modules to be used, obtaining different configurations with the flexibility to adapt to various workloads. With the goal to maximize energy efficiency, the HiVe can be configured with each of the Infiniband connected nodes provided with a CPU board mounting the AppliedMicro SoC in combination with 4 of the latest GPUs or coprocessors. Such system configuration has been successfully tested with a set of applications running on Linux CentOS operating system.

About Eurotech

Eurotech (ETH.MI) is a global company based in Italy and with subsidiaries in Europe, North America and Asia. The Eurotech Group develops and markets HPC systems and miniaturized computers for special uses (NanoPCs). The Eurotech HPC division has more than 15 years of experience in designing and manufacturing HPC systems, with a commitment to continuous innovation through R&D nurtured in house and in collaboration with the most important research centres in Europe. Eurotech HPC designs and delivers solutions that help customers to maximize results while minimizing time to market and TCO. Learn more about Eurotech at www.eurotech.com

About AppliedMicro

Applied Micro Circuits Corporation (NASDAQ:AMCC) is a global leader in computing and connectivity solutions for next-generation cloud infrastructure and data centers. AppliedMicro delivers silicon solutions that dramatically lower total cost of ownership. Corporate headquarters are located in Santa Clara, California. www.apm.com.

(C) Copyright 2015, Applied Micro Circuits Corporation. AppliedMicro, X-Gene, X-Weave, Server on a Chip, and Cloud Server are registered trademarks of Applied Micro Circuits Corporation. All other product or service names are the property of their respective owners.

Company contacts: Giovanbattista Mattiussi Marketing Manager HPC, Eurotech Mike Major Applied Micro Circuits Corporation Phone: (408) 542-8831 Jennifer Grabowski Racepoint Global for Applied Micro Circuits Corporation Phone: +1-617-624-3231

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 79

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 421

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 72

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 140

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 93

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 149

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 312

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 87

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading

Top 5 Most Recently Viewed Articles

Nippon Express Europe Partners with Formag for Logistics Support

Updated Category News Views 213

Nippon Express Europe and Formag Form New Logistics Partnership Nippon Express Europe GmbH, part of NIPPON EXPRESS HOLDINGS, INC., has recently signed a cooperation agreement with Ukrainian logistics provider, Formag-Kiev. This significant collaboration aims to provide essential logistical support for the reconstruction of Ukraine. Commitment to Ukrainian Reconstruction...

Continue Reading
Escalating Legal Action Over LIBRA Token Sparks Controversy

Updated Category News Views 265

Legal Developments in the LIBRA Token Case A prominent Argentine lawyer has made headlines by calling for global law enforcement to apprehend a cryptocurrency figure involved in the LIBRA token controversy. Details of the Extradition Request Gregorio Dalbon, known for his defense work with former Argentine President Cristina Fernandez in a prominent corruption matter, has...

Continue Reading
Tesla Prevails in Motion to Dismiss Racial Bias Lawsuit

Updated Category News Views 230

Tesla's Legal Victory Against Racial Bias Allegations Under the direction of Elon Musk, Tesla Inc. (NASDAQ: TSLA) has successfully overturned a significant class action lawsuit that was brought forth by more than 6,000 African American workers. These workers alleged racial discrimination at Tesla's Fremont assembly plant. This ruling is a key moment in the ongoing...

Continue Reading
ZenaTech Unveils Specialized AI Hub to Bolster US Defense Tactics

Updated Category News Views 100

ZenaTech Launches Innovative AI Development Center Vancouver, British Columbia – ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) has taken a significant stride toward advancing artificial intelligence technologies by establishing Zena AI, Inc. This new AI Development Center will focus on crafting specialized AI solutions tailored for defense and homeland security...

Continue Reading
Investors Reminded of Action Timeline Against ICON plc - ICLR

Updated Category News Views 172

Understanding the Legal Proceedings Against ICON plc In an important reminder for shareholders, Kahn Swick & Foti, LLC is emphasizing the critical timeline for investors affected by losses from their holdings in ICON plc (NASDAQ: ICLR). The firm, led by former Louisiana Attorney General Charles C. Foti, Jr., is urging investors who incurred losses exceeding $100,000 to...

Continue Reading